Username
Password
Forget Password?
  1. Indices
  2. Commodities
  3. Currencies
Straits Times 3,158.80 -8.04 -0.25%
Hang Seng 26,468.95 -285.17 -1.07%
Dow Jones 27,094.79 -52.29 -0.19%
Shanghai Composite 2,999.28 +13.62 +0.46%
Singapore Medical Group Enters MOU For Cardiac Monitoring Joint Venture
Daily Bulletin | 08 October 2015
Related stocks:
5OT
By:

Singapore Medical Group has announced entering into a non-binding memorandum of understanding (MOU) with Cardioscan in relation to a proposed joint venture to engage in the provision of cardiac monitoring and reporting services in Singapore, Malaysia and Indonesia.

Cardioscan is a company incorporated in Australia principally engaged in the provision of cardiac monitoring and reporting services in Australia and is currently the largest private cardiac monitoring company in Australia.

Pursuant to the MOU, the group and Cardioscan will each hold 50 percent equity interest in the joint venture entity. The MOU is valid for 90 days and is subject to the completion of the following matters: Registration of holter equipment in Singapore; formalisation of business plan; and entry into a definitive shareholders’ agreement by the group and Cardioscan.

Singapore Medical Group  0.325 +0.015 +4.84%   
Business: Co is a private specialist healthcare provider in Singapore. [FY18 Turnover] Health (70.7%), aesthetics (28.6%), others (0.7%).

Insight: Feb-19, FY18 revenue jumped 25.1% to $85.1m driven... Read More


Join The Conversation
The Shares Investment editorial team welcomes constructive feedback on our coverage and content. We would also be delighted to answer any questions on the above article. Leave us a comment below, and we'll get back to you shortly!

All Rights Reserved. Pioneers & Leaders (Publishers) Pte Ltd. Best viewed with Mozilla Firefox 3.5 and above.